Strides Pharma gains 6% as JV receives approval for Albendazole tablets

The stock moved higher by 6.4% to Rs 458 on BSE after the company announced that its JV has received USFDA nod for tapeworm infection treatment drug.

from Latest News https://ift.tt/2C2rfEf
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share